Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

The present study aimed to investigate the impact of pre-treatment C-reactive protein (CRP) levels on the prediction of prognosis in patients with metastatic renal cell carcinoma (mRCC), who were classified as intermediate-risk patients using the Memorial Sloan Kettering Cancer Center (MSKCC) risk c...

Descripción completa

Detalles Bibliográficos
Autores principales: TEISHIMA, JUN, KOBATAKE, KOHEI, HAYASHI, TETSUTARO, SENO, YASUYUKI, IKEDA, KENICHIRO, NAGAMATSU, HIROTAKA, HIEDA, KEISUKE, SHOJI, KOICHI, MIYAMOTO, KATSUTOSHI, INOUE, SHOGO, KOBAYASHI, KANAO, OHARA, SHINYA, KAJIWARA, MITSURU, MATSUBARA, AKIO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081304/
https://www.ncbi.nlm.nih.gov/pubmed/25013512
http://dx.doi.org/10.3892/ol.2014.2207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081304/
https://www.ncbi.nlm.nih.gov/pubmed/25013512
http://dx.doi.org/10.3892/ol.2014.2207

Ejemplares similares